Hyperglycemia in sepsis can downregulate CSE expression in the liver and thereby compromise PGC1α signaling, reduce mitochondrial activity, and promote lipid droplet formation—all early signs of liver damage, which may ultimately manifest as fatty liver disease and hepatic steatosis [17]. This evidence concerns the gene PPARGC1A and Sepsis.